Dr Capo-Chichi is a clinical scientist and director of malignant hematology genomics at the Genome Diagnostics Laboratory at University Health Network in Toronto. He is an assistant professor in the department of Laboratory Medicine and Pathobiology at the University of Toronto. He is a clinician investigator at the Princess Margaret Cancer Centre Research Institute with a primary focus on the genomic bases of acquired and inherited myeloid malignancies. His interest include the improvement of traditional genomic approaches and the development of novel clinical tests for diagnosis and prognostication of cancers, using high-throughput genotyping strategies.

Dr. Trottier is originally from Halifax and completed her undergraduate degree and a Master's in physical chemistry at Dalhousie University before entering into medical school. She completed medical school training at Dalhousie University then moved to Calgary for Internal Medicine and Hematology residencies. It was while in Calgary, that she became exposed to and interested in patients and families that seemed predisposed to developing hematologic malignancies. She pursued this interest through undertaking a postdoctoral research fellowship at the University of Chicago. She moved back to Halifax in January of 2020 where she currently works as an associate professor in the division of hematology and hematologic oncology. She runs a local translational research program and established a hereditary hematologic malignancy risk clinic, the first of its kind in Canada, with local clinical germline genetic testing capabilities for hereditary hematologic malignancy syndromes.